NCT05824403Recruiting
PAncreatic Disease Cohort of TOuLouse
Source: ClinicalTrials.gov · Last updated 4 Dec 2023 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This study is a prospective cohort dedicated to pancreatic diseases excluding cancer. The aim is to develop positive or differential diagnostic tools between benign potentially malignant or malignant pancreatic pathologies. During this study the investigators collect data and biological samples to support research project.
- Status (registry)
- Recruiting
- Study type
- Observational
- Enrollment
- 300 (estimated)
- First submitted
- 27 Mar 2023
- Start date
- 28 Nov 2023
- Primary completion date
- Dec 2027
- Lead sponsor
- University Hospital, Toulouse
- NCT number
- NCT05824403
What you commit to
- Study type: Observational
- Planned participants: 300
- From 28 Nov 2023 to the primary completion date, Dec 2027
- 1 site in 1 country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Other illness
- Patient with pancreatic cancer pathology
- Patients with active cancer, whatever the origin
Other
- Pregnant or breastfeeding patients
- Patients under legal protection, guardianship or trusteeship
Who the study is looking for
- Patients with inflammatory or cystic exocrine pancreatic pathology
- Patient able to read and understand the information leaflet
- Patients who have agreed to participate in the study and have signed the free and informed consent
- Patients affiliated to a social security system (including AME)
Age in the registry: 18 years to - · Sex: All
Sites (1)
Sites in registry order. Pick your city on the disease page to sort them by distance.
| Site | City | Country | Site status |
|---|---|---|---|
| Rangueil hospital Coordinator of this site? Confirm its status | Toulouse | France | Recruiting |
This page is information, not medical advice. Discuss any trial with your doctor.